'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author's reply.
作者信息
Broman Niklas, Feuth Thijs, Oksi Jarmo
机构信息
Departments of Infectious Diseases and Pulmonary Diseases, Turku University Hospital, Turku, Finland.
Departments of Infectious Diseases and Pulmonary Diseases, Turku University Hospital, Turku, Finland.
出版信息
Clin Microbiol Infect. 2022 Nov;28(11):1520-1521. doi: 10.1016/j.cmi.2022.06.028. Epub 2022 Jul 4.
Abstract
摘要
相似文献
1
'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author's reply.“在炎症标志物升高的住院COVID-19患者中早期使用托珠单抗；COVIDSTORM”——作者回复
Clin Microbiol Infect. 2022 Nov;28(11):1520-1521. doi: 10.1016/j.cmi.2022.06.028. Epub 2022 Jul 4.
2
Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM.回复：在炎症标志物升高的住院COVID-19患者中早期使用托珠单抗；COVIDSTORM研究。
Clin Microbiol Infect. 2022 Nov;28(11):1519. doi: 10.1016/j.cmi.2022.06.013. Epub 2022 Jun 20.
3
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study.COVID-19 住院患者炎症标志物升高时早期使用托珠单抗；COVIDSTORM 前瞻性、随机、单中心、开放标签研究。
Clin Microbiol Infect. 2022 Jun;28(6):844-851. doi: 10.1016/j.cmi.2022.02.027. Epub 2022 Mar 5.
4
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's reply.托珠单抗治疗新冠肺炎患者的疗效和安全性：一项实时系统评价与荟萃分析——作者回复
Clin Microbiol Infect. 2021 Aug;27(8):1177-1178. doi: 10.1016/j.cmi.2021.02.024. Epub 2021 Mar 8.
5
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection.托珠单抗使用时机对住院的2019冠状病毒病感染患者的影响
Respir Care. 2022 May;67(5):629-630. doi: 10.4187/respcare.10067.
6
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.托珠单抗治疗新冠病毒肺炎住院患者
N Engl J Med. 2021 Apr 15;384(15):1473. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3.
7
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.托珠单抗治疗期间伴 MOG 抗体相关疾病的良性 SARS-CoV-2 感染。
Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.
8
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.托珠单抗用于新冠肺炎肺炎住院患者。回复。
N Engl J Med. 2021 Apr 15;384(15):1473-1474. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3.
9
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.托珠单抗用于新冠肺炎肺炎住院患者。回复。
N Engl J Med. 2021 Apr 15;384(15):1474. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3.
10
Dosing and Administration Strategies of Tocilizumab in Patients With COVID-19: A Retrospective Cohort Analysis.托珠单抗在 COVID-19 患者中的剂量和给药策略：一项回顾性队列分析。
Ann Pharmacother. 2024 Apr;58(4):391-397. doi: 10.1177/10600280231190401. Epub 2023 Jul 31.
引用本文的文献
1
Complex changes in serum protein levels in COVID-19 convalescents.新型冠状病毒肺炎恢复期患者血清蛋白水平的复杂变化。
Sci Rep. 2024 Feb 23;14(1):4479. doi: 10.1038/s41598-024-54534-7.
本文引用的文献
1
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study.COVID-19 住院患者炎症标志物升高时早期使用托珠单抗；COVIDSTORM 前瞻性、随机、单中心、开放标签研究。
Clin Microbiol Infect. 2022 Jun;28(6):844-851. doi: 10.1016/j.cmi.2022.02.027. Epub 2022 Mar 5.
Zotero 插件